AGPS

Chr 2AR

alkylglycerone phosphate synthase

Also known as: ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY, RCDP3

This gene is a member of the FAD-binding oxidoreductase/transferase type 4 family. It encodes a protein that catalyzes the second step of ether lipid biosynthesis in which acyl-dihydroxyacetonephosphate (DHAP) is converted to alkyl-DHAP by the addition of a long chain alcohol and the removal of a long-chain acid anion. The protein is localized to the inner aspect of the peroxisomal membrane and requires FAD as a cofactor. Mutations in this gene have been associated with rhizomelic chondrodysplasia punctata, type 3 and Zellweger syndrome. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.121 OMIM phenotype
Clinical SummaryAGPS
🧬
Gene-Disease Validity (ClinGen)
alkylglycerone-phosphate synthase deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
31 unique Pathogenic / Likely Pathogenic· 207 VUS of 816 total submissions
📖
GeneReview available — AGPS
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.12LOEUF
pLI 1.000
Z-score 5.75
OE 0.02 (0.010.12)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
3.23Z-score
OE missense 0.52 (0.460.59)
186 obs / 357.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.02 (0.010.12)
00.351.4
Missense OE?0.52 (0.460.59)
00.61.4
Synonymous OE?0.98
01.21.6
LoF obs/exp: 1 / 40.5Missense obs/exp: 186 / 357.9Syn Z: 0.15
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveAGPS-related rhizomelic chondrodysplasia punctataLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.3296th %ile
GOF
0.3789th %ile
LOF
0.72top 10%

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

816 submitted variants in ClinVar

Classification Summary

Pathogenic8
Likely Pathogenic23
VUS207
Likely Benign469
Benign72
Conflicting18
8
Pathogenic
23
Likely Pathogenic
207
VUS
469
Likely Benign
72
Benign
18
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
5
2
1
0
8
Likely Pathogenic
20
2
1
0
23
VUS
3
114
84
6
207
Likely Benign
0
1
210
258
469
Benign
0
0
68
4
72
Conflicting
18
Total28119364268797

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

32 pathogenic / likely-pathogenic (of 36) ClinVar copy-number / structural variants overlap AGPS — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

AGPS · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →